Kineta is a Washington-based biotechnology company that researches and develops novel immunotherapies for the treatment of cancer.
$2.4M
Feb 21, 2022
-
Kineta is a Washington-based biotechnology company that researches and develops novel immunotherapies for the treatment of cancer.
$17.4M
May 27, 2021
-
GoodFinch is a US-based financial firm that offers environmental, social, and governance investment services for businesses.
$145M
Dec 23, 2020
-